Publikationer och posters

Dessa publikationer kan innehålla resultat från en eller flera organism-/antibiotikakombinationer som endast är för forskningsbruk och inte godkända för diagnostiskt bruk. Vissa systemfunktioner som beskrivs i dessa publikationer är endast för forskningsbruk och har inte godkänts för diagnostisk använding.

År Titel Ladda ned
2023 A new assay for rapid antimicrobial susceptibility testing of bloodstream infection-causing gram-negative bacteria. Posterpresentation, ASM 2023.
2023 Performance Evaluation for Piperacillin/Tazobactam in ESBL-Producing E. coli Strains (OXA-1 and TEM-1) in an Automated Rapid AST System Using the New FDA Breakpoints. Posterpresentation, ASM 2023.
2021 Fully Automated Phenotypic Resistance Reporting in 3 Hours, Directly from a Positive Blood Culture. Poster presentation, ECCMID 2021.
2021 ASTar Broschyr - Designed to save lifetimes
2021 Applikationsnot - Advantages of the ASTar System
2020 Applikationsnot - A workflow for early and accurate treatment of sepsis
2019 Accurate inoculum preparation for AST from various samples. Poster presentation, ASM 2019.
2019 Rapid phenotypic AST direct from different clinical specimens as well as isolates on the same automated system. Poster presentation, ECCMID 2019.
2019 Automated inoculum preparation for AST from crude samples. Poster presentation, ECCMID 2019.
2018 Antimicrobial Susceptibility Test System Delivering Phenotypic MICs in Hours from Positive Blood Cultures for Fastidious- and Non-Fastidious Pathogens. Poster presentation, ASM 2018.
2018 Opportunity for very rapid phenotypic susceptibility testing of clinical specimens using the novel ASTar platform. Poster presentation, ASM 2018.
2018 MALDI-TOF MS Identification and Phenotypic AST Delivering True MICs in Hours, Directly from Clinical Positive Blood Cultures. Poster presentation, ASM 2018.
2018 Mass spectrometry pathogen identification and phenotypic antimicrobial susceptibility testing delivering MICs in hours, directly from clinical positive blood cultures. Poster presentation, ECCMID 2018.
2022 White Paper - The Importance of Controlled Inoculum
2022 Performance of a rapid phenotypic AST System for susceptibility testing of Gram-negative bacteraemia directly from positive blood culture bottles
2022 Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing
2022 Rapid phenotypic AST System performance for Gram-negative bacteraemia susceptibility testing directly from positive blood culture bottles
2022 Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing ASM 2022

Hör av dig

VP, Director Research

Mats Gullberg
mats.gullberg@qlinea.com
Mobil: +46 (0)70 786 09 08

Cheif Commercial Officer

Thomas Fritz
thomas.fritz@qlinea.com